BREAKING THE PAIN-OPIOID CYCLE: THE PROMISE OF SPINAL CORD STIMULATORS

Introduction: Chronic pain affects approximately 20% of U.S. adults, imposing an economic burden of billions of dollars annually. The use of opioids for pain management has contributed to a public health crisis, with over two million Americans diagnosed with opioid use disorder. Non-pharmacological options, like spinal cord stimulators (SCS), offer a promising management option. Methods: A comprehensive literature review was conducted using a variety of databases. Keywords included "chronic pain", "opioid use disorder", "pain management", and "spinal cord stimulation". Inclusion criteria focused on studies published in peer-reviewed journals discussing SCS efficacy in adults with non-cancer-related chronic pain. Results: Evidence implies SCS significantly reduces pain and opioid consumption in patients with chronic pain. It is most effective in those with neuropathic pain. Improvement in quality of life, functionality, and patient satisfaction were mentioned. Long-term outcomes require further research. Discussion: SCS is a promising solution to chronic pain and opioid dependency through the disruption of pain signaling and modulation of neural pathways. Challenges like high costs, invasive procedures, and variability of outcomes in patients need to be addressed. Conclusion: SCS is a favorable alternative to opioids for managing chronic pain. Further research is needed to optimize patient selection, refine techniques, and address accessibility to maximize the impact on the population.